Log in to save to my catalogue

Gepants, calcitonin gene-related peptide antagonists, for abortive treatment of migraine: current st...

Gepants, calcitonin gene-related peptide antagonists, for abortive treatment of migraine: current st...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_18203_2319_2003_ijbcp20213373

Gepants, calcitonin gene-related peptide antagonists, for abortive treatment of migraine: current status

About this item

Full title

Gepants, calcitonin gene-related peptide antagonists, for abortive treatment of migraine: current status

Journal title

International journal of basic and clinical pharmacology, 2021-09, Vol.10 (9), p.1156

Language

English

Formats

More information

Scope and Contents

Contents

Migraine is a neurovascular disorder characterized by unilateral, recurrent, pulsating, throbbing, and moderate to severe headache. Triptans use is often limited by their poor efficacy, reports of poor responders, and contraindicated in patients with cardiovascular disorders. Calcitonin gene-related peptide (CGRP), a neuropeptide, regulates vascula...

Alternative Titles

Full title

Gepants, calcitonin gene-related peptide antagonists, for abortive treatment of migraine: current status

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_18203_2319_2003_ijbcp20213373

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_18203_2319_2003_ijbcp20213373

Other Identifiers

ISSN

2319-2003

E-ISSN

2279-0780

DOI

10.18203/2319-2003.ijbcp20213373

How to access this item